Biotech Investors Should Consider The Four Horsemen
July 6, 2018
Multiparametric liver MRI could refine the way we currently approach testing of therapeutic candidates in preclinical models
July 3, 2018
Analysis of Biobank data shows 1 in 8 adults may have NASH
April 15, 2018
LiverMultiScan™ analysis of UK Biobank indicates as many as 1 in 8 adults may have non-alcoholic steatohepatitis (NASH)
April 13, 2018
LiverMultiScan™ Receives FDA 510(k) Clearance for Version 2 of Medical Device
November 27, 2017
LITMUS Project – LiverMultiScan™ included in ground-breaking €34 million project to develop better test for liver disease
November 24, 2017
